C07D 417/14
Containing three or more hetero rings
Official title: containing three or more hetero rings
C07D417/14 (Containing three or more hetero rings) appears on 8,056 US grants and 10,615 published applications in this corpus.
Search patents in C07D- Granted patents
- 8,056
- Published applications
- 10,615
- Assignees
- 2,497
- Inventors
- 23,867
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 7 | 0 |
| 1985 | 17 | 0 |
| 1986 | 17 | 0 |
| 1987 | 32 | 0 |
| 1988 | 33 | 0 |
| 1989 | 44 | 0 |
| 1990 | 43 | 0 |
| 1991 | 53 | 0 |
| 1992 | 47 | 0 |
| 1993 | 41 | 0 |
| 1994 | 45 | 0 |
| 1995 | 50 | 0 |
| 1996 | 69 | 0 |
| 1997 | 92 | 0 |
| 1998 | 74 | 0 |
| 1999 | 73 | 0 |
| 2000 | 81 | 0 |
| 2001 | 117 | 23 |
| 2002 | 121 | 117 |
| 2003 | 135 | 262 |
| 2004 | 115 | 371 |
| 2005 | 125 | 341 |
| 2006 | 187 | 335 |
| 2007 | 180 | 349 |
| 2008 | 187 | 325 |
| 2009 | 235 | 445 |
| 2010 | 280 | 537 |
| 2011 | 280 | 457 |
| 2012 | 350 | 427 |
| 2013 | 424 | 487 |
| 2014 | 483 | 535 |
| 2015 | 449 | 514 |
| 2016 | 404 | 482 |
| 2017 | 418 | 452 |
| 2018 | 363 | 480 |
| 2019 | 387 | 458 |
| 2020 | 345 | 459 |
| 2021 | 310 | 405 |
| 2022 | 268 | 444 |
| 2023 | 248 | 591 |
| 2024 | 269 | 507 |
| 2025 | 308 | 473 |
| 2026 | 229 | 339 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Double degraders and uses thereof6 Oct 2026US 12,753,172 B2Kymera Therapeutics, Inc.
- Amorphous substances, crystals, pharmaceutical compositions, preparation methods and uses of thiohydantoin compound or pharmaceutically acceptable salt thereof6 Oct 2026US 12,753,173 B2Suzhou Kintor Pharmaceuticals, Inc.
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Cdk2 inhibitors and methods of using same8 Oct 2026US 2026/0308145 A1Guangdong Touchstone Translational Research Institute Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- 1,3,4-thiadiazol-2-yl carboxamide and 1,3-thiazol-2-yl carboxamide compounds and uses thereof as inhibitors of human polymerase theta1 Oct 2026US 2026/0294921 A1Gilead Sciences, Inc.
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
Most cited
By later US patents
- Morpholino-subunit combinatorial library and method422US 5,506,337 AAntivirals Inc. · 1996
- Morpholino-subunit combinatorial library and method402US 5,698,685 AAntivirals Inc. · 1997
- Substituted unsymmetrical cyanine dyes with selected permeability384US 5,658,751 AMolecular Probes, Inc. · 1997
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995
- Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents332US 6,603,008 B1Pfizer Inc. · 2003